Compare SOPH & RMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SOPH | RMM |
|---|---|---|
| Founded | 2011 | 2019 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.7M | 276.2M |
| IPO Year | 2021 | N/A |
| Metric | SOPH | RMM |
|---|---|---|
| Price | $5.07 | $14.38 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 350.7K | 66.5K |
| Earning Date | 03-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.33% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.96 |
| Revenue | ★ $73,297,000.00 | N/A |
| Revenue This Year | $18.48 | N/A |
| Revenue Next Year | $15.82 | N/A |
| P/E Ratio | ★ N/A | $15.55 |
| Revenue Growth | ★ 13.66 | N/A |
| 52 Week Low | $2.58 | $12.32 |
| 52 Week High | $5.70 | $16.10 |
| Indicator | SOPH | RMM |
|---|---|---|
| Relative Strength Index (RSI) | 47.65 | 74.39 |
| Support Level | $5.01 | $13.79 |
| Resistance Level | $5.62 | $14.09 |
| Average True Range (ATR) | 0.33 | 0.13 |
| MACD | -0.05 | 0.05 |
| Stochastic Oscillator | 15.19 | 89.44 |
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
RiverNorth Managed Duration Muni Inc Fd is a United States based diversified, closed-end management investment company. Its primary investment objective is current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.